奈西立肽 - 未经验证。 - Suppr

Suppr

超能文献

Nesiritide - not verified.

作者信息

Topol Eric J

机构信息

Case Western Reserve University, Cleveland, USA.

出版信息

N Engl J Med. 2005 Jul 14;353(2):113-6. doi: 10.1056/NEJMp058139.

DOI:10.1056/NEJMp058139

PMID:16014879

Abstract

摘要

相似文献

Nesiritide - not verified.

N Engl J Med. 2005 Jul 14;353(2):113-6. doi: 10.1056/NEJMp058139.

Nesiritide--not verified.

N Engl J Med. 2005 Oct 6;353(14):1525-7; author reply 1525-7. doi: 10.1056/NEJMc052142.

Nesiritide--not verified.

N Engl J Med. 2005 Oct 6;353(14):1525-7; author reply 1525-7.

Nesiritide--not verified.

N Engl J Med. 2005 Oct 6;353(14):1525-7; author reply 1525-7.

Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.

Pharmacotherapy. 2007 May;27(5):619-25. doi: 10.1592/phco.27.5.619.

The rise and fall of Natrecor for congestive heart failure: implications for drug policy.

Health Aff (Millwood). 2006 Jul-Aug;25(4):1095-102. doi: 10.1377/hlthaff.25.4.1095.

Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.

Pharmacotherapy. 2007 May;27(5):626-32. doi: 10.1592/phco.27.5.626.

Critical review and recommendations for nesiritide use in the emergency department.

J Emerg Med. 2005 Oct;29(3):317-29. doi: 10.1016/j.jemermed.2005.01.028.

The lost decade of nesiritide.

N Engl J Med. 2011 Jul 7;365(1):81-2. doi: 10.1056/NEJMe1103116.

Efficacy and safety of nesiritide in patients with acute decompensated heart failure.

Expert Rev Cardiovasc Ther. 2010 Feb;8(2):159-69. doi: 10.1586/erc.09.173.

引用本文的文献

Discovery of -glycans on atrial natriuretic peptide (ANP) that affect both its proteolytic degradation and potency at its cognate receptor.

J Biol Chem. 2019 Aug 23;294(34):12567-12578. doi: 10.1074/jbc.RA119.008102. Epub 2019 Jun 11.

Gaps in the Heart Failure Guidelines.

Eur Cardiol. 2014 Dec;9(2):104-109. doi: 10.15420/ecr.2014.9.2.104.

Gaps in the Heart Failure Guidelines.

Card Fail Rev. 2015 Apr;1(1):50-55. doi: 10.15420/CFR.2015.01.01.50.

Section 3: Prevention and Treatment of AKI.

Kidney Int Suppl (2011). 2012 Mar;2(1):37-68. doi: 10.1038/kisup.2011.33.

Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).

Crit Care. 2013 Feb 4;17(1):204. doi: 10.1186/cc11454.

Sorrell v. IMS Health: issues and opportunities for informaticians.

J Am Med Inform Assoc. 2013 Jan 1;20(1):35-7. doi: 10.1136/amiajnl-2012-001123. Epub 2012 Oct 27.

Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.

J Lipid Res. 2012 Sep;53(9):1767-82. doi: 10.1194/jlr.R024190. Epub 2012 Jun 4.

Emerging therapies for heart failure: renal mechanisms and effects.

Heart Fail Rev. 2012 Jan;17(1):1-16. doi: 10.1007/s10741-010-9191-5.

Clinical practice: heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial medical management.

Eur J Pediatr. 2010 Mar;169(3):269-79. doi: 10.1007/s00431-009-1024-y. Epub 2009 Aug 26.

Nesiritide in acute decompensated heart failure: current status and future perspectives.

Rev Cardiovasc Med. 2008 Summer;9(3):151-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Nesiritide - not verified.

N Engl J Med. 2005 Jul 14;353(2):113-6. doi: 10.1056/NEJMp058139.

Nesiritide--not verified.

N Engl J Med. 2005 Oct 6;353(14):1525-7; author reply 1525-7. doi: 10.1056/NEJMc052142.

Nesiritide--not verified.

N Engl J Med. 2005 Oct 6;353(14):1525-7; author reply 1525-7.

Nesiritide--not verified.

N Engl J Med. 2005 Oct 6;353(14):1525-7; author reply 1525-7.

Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.

Pharmacotherapy. 2007 May;27(5):619-25. doi: 10.1592/phco.27.5.619.

The rise and fall of Natrecor for congestive heart failure: implications for drug policy.

Health Aff (Millwood). 2006 Jul-Aug;25(4):1095-102. doi: 10.1377/hlthaff.25.4.1095.

Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.

Pharmacotherapy. 2007 May;27(5):626-32. doi: 10.1592/phco.27.5.626.

Critical review and recommendations for nesiritide use in the emergency department.

J Emerg Med. 2005 Oct;29(3):317-29. doi: 10.1016/j.jemermed.2005.01.028.

The lost decade of nesiritide.

N Engl J Med. 2011 Jul 7;365(1):81-2. doi: 10.1056/NEJMe1103116.

Efficacy and safety of nesiritide in patients with acute decompensated heart failure.

Expert Rev Cardiovasc Ther. 2010 Feb;8(2):159-69. doi: 10.1586/erc.09.173.

引用本文的文献

Discovery of -glycans on atrial natriuretic peptide (ANP) that affect both its proteolytic degradation and potency at its cognate receptor.

J Biol Chem. 2019 Aug 23;294(34):12567-12578. doi: 10.1074/jbc.RA119.008102. Epub 2019 Jun 11.

Gaps in the Heart Failure Guidelines.

Eur Cardiol. 2014 Dec;9(2):104-109. doi: 10.15420/ecr.2014.9.2.104.

Gaps in the Heart Failure Guidelines.

Card Fail Rev. 2015 Apr;1(1):50-55. doi: 10.15420/CFR.2015.01.01.50.

Section 3: Prevention and Treatment of AKI.

Kidney Int Suppl (2011). 2012 Mar;2(1):37-68. doi: 10.1038/kisup.2011.33.

Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).

Crit Care. 2013 Feb 4;17(1):204. doi: 10.1186/cc11454.

Sorrell v. IMS Health: issues and opportunities for informaticians.

J Am Med Inform Assoc. 2013 Jan 1;20(1):35-7. doi: 10.1136/amiajnl-2012-001123. Epub 2012 Oct 27.

Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.

J Lipid Res. 2012 Sep;53(9):1767-82. doi: 10.1194/jlr.R024190. Epub 2012 Jun 4.

Emerging therapies for heart failure: renal mechanisms and effects.

Heart Fail Rev. 2012 Jan;17(1):1-16. doi: 10.1007/s10741-010-9191-5.

Clinical practice: heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial medical management.

Eur J Pediatr. 2010 Mar;169(3):269-79. doi: 10.1007/s00431-009-1024-y. Epub 2009 Aug 26.

Nesiritide in acute decompensated heart failure: current status and future perspectives.

Rev Cardiovasc Med. 2008 Summer;9(3):151-8.